NIMU

NON INVASIVE MONITORING SYSTEMS INC /FL/

Export transactions ↓

Tapewire entity: 7976
SEC CIK: 0000720762
Parsed reports: 5

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.

Nov

Dec

Jan

Feb

Mar

Apr

May

Jun

Jul

Aug

Sep

Oct

Monthly counts

Month	Purchases	Sales
Nov 2025	0	0
Dec 2025	0	0
Jan 2026	0	0
Feb 2026	0	0
Mar 2026	0	0
Apr 2026	0	0
May 2026	0	0
Jun 2026	0	0
Jul 2026	0	0
Aug 2026	0	0
Sep 2026	0	0
Oct 2026	0	0

Latest available

Insider transactions

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Owner / reported role	Activity / security	Shares / units	Reported price	Reported value	Details
January 24, 2019 Filed Jan 28, 2019 21:29 UTC	FROST PHILLIP MD ET AL10% owner Frost Gamma Investments Trust10% owner	ConversionSeries D Convertible Preferred Stock · Derivative	1,267	$0.00	$0.00	Disclosure SEC source: 0001493152-19-001029 · ownership.xml · derivative · entry 2 FROST PHILLIP MD ET AL · CIK 0000898860 · 10% owner Frost Gamma Investments Trust · CIK 0001380896 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Frost Gamma Investments Trust Disclosed balance after: 0 Underlying: Common Stock · 6,335,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series D Convertible Preferred Stock converted into 5,000 shares of common stock and had no expiration date. F1 · derivative.exercise_date: Each share of Series D Convertible Preferred Stock converted into 5,000 shares of common stock and had no expiration date. F1 · derivative.expiration_date: Each share of Series D Convertible Preferred Stock converted into 5,000 shares of common stock and had no expiration date. F2 · ownership.nature: The securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
January 24, 2019 Filed Jan 28, 2019 21:29 UTC	FROST PHILLIP MD ET AL10% owner Frost Gamma Investments Trust10% owner	ConversionCommon Stock, $0.01 par value per share	6,335,000	Not disclosed	Not disclosed	Disclosure SEC source: 0001493152-19-001029 · ownership.xml · nonDerivative · entry 1 FROST PHILLIP MD ET AL · CIK 0000898860 · 10% owner Frost Gamma Investments Trust · CIK 0001380896 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Frost Gamma Investments Trust Disclosed balance after: 54,690,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series D Convertible Preferred Stock converted into 5,000 shares of common stock and had no expiration date. F2 · ownership.nature: The securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
December 21, 2018 Filed Dec 28, 2018 00:36 UTC	HSIAO JANE PH DDirector · Interim CEO · 10% owner	PurchaseCommon Stock, $0.01 par value per share	20,883,660	$0.07	$1,461,856.20	Disclosure SEC source: 0001493152-18-018021 · ownership.xml · nonDerivative · entry 3 HSIAO JANE PH D · CIK 0001188834 · Director · Interim CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 20,883,660 F1 · shares: Shares acquired in exchange for indebtedness owed by Non-Invasive Monitoring Systems, Inc. to the reporting person or affiliates thereof. F1 · price: Shares acquired in exchange for indebtedness owed by Non-Invasive Monitoring Systems, Inc. to the reporting person or affiliates thereof. F2 · ownership.nature: Held by Hsu Gamma Investments LP, of which the reporting person is the general partner. The reporting person disclaims beneficial ownership of all shares held by Hsu Gamma Investments, LP except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document
December 21, 2018 Filed Dec 28, 2018 00:36 UTC	HSIAO JANE PH DDirector · Interim CEO · 10% owner	PurchaseCommon Stock, $0.01 par value per share	4,923,503	$0.07	$344,645.21	Disclosure SEC source: 0001493152-18-018021 · ownership.xml · nonDerivative · entry 2 HSIAO JANE PH D · CIK 0001188834 · Director · Interim CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,752,074 F1 · shares: Shares acquired in exchange for indebtedness owed by Non-Invasive Monitoring Systems, Inc. to the reporting person or affiliates thereof. F1 · price: Shares acquired in exchange for indebtedness owed by Non-Invasive Monitoring Systems, Inc. to the reporting person or affiliates thereof. Read SEC document
December 21, 2018 Filed Dec 28, 2018 00:36 UTC	HSIAO JANE PH DDirector · Interim CEO · 10% owner	PurchaseCommon Stock, $0.01 par value per share	1,428,571	$0.07	$99,999.97	Disclosure SEC source: 0001493152-18-018021 · ownership.xml · nonDerivative · entry 1 HSIAO JANE PH D · CIK 0001188834 · Director · Interim CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,828,571 Read SEC document
December 21, 2018 Filed Dec 28, 2018 00:22 UTC	FROST PHILLIP MD ET AL10% owner Frost Gamma Investments Trust10% owner	PurchaseCommon Stock, $0.01 par value per share	26,212,468	$0.07	$1,834,872.76	Disclosure SEC source: 0001493152-18-018019 · ownership.xml · nonDerivative · entry 2 FROST PHILLIP MD ET AL · CIK 0000898860 · 10% owner Frost Gamma Investments Trust · CIK 0001380896 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Frost Gamma Investments Trust Disclosed balance after: 48,355,325 F2 · shares: Shares acquired in exchange for indebtedness owed by Non-Invasive Monitoring Systems, Inc. to the reporting person or affiliates thereof. F2 · price: Shares acquired in exchange for indebtedness owed by Non-Invasive Monitoring Systems, Inc. to the reporting person or affiliates thereof. F1 · ownership.nature: The securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
December 21, 2018 Filed Dec 28, 2018 00:22 UTC	FROST PHILLIP MD ET AL10% owner Frost Gamma Investments Trust10% owner	PurchaseCommon Stock, $0.01 par value per share	7,142,857	$0.07	$499,999.99	Disclosure SEC source: 0001493152-18-018019 · ownership.xml · nonDerivative · entry 1 FROST PHILLIP MD ET AL · CIK 0000898860 · 10% owner Frost Gamma Investments Trust · CIK 0001380896 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Frost Gamma Investments Trust Disclosed balance after: 22,142,857 F1 · ownership.nature: The securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.